Crossed cerebellar diaschisis in Alzheimer's disease. Issue 4 (25th January 2022)

• Record Type: Journal Article
• Authors: Tripathi, Shailendra Mohan; Murray, Alison D.; Wischik, Claude M.; Schelter, Bjoern
• Is Part Of: Nuclear medicine communications. Volume 43:Issue 4(2022)
• Page Start: 423
• Page End: 427
• Publication Date: 2022-01-25
• Subjects: Alzheimer's disease -- crossed cerebellar diaschisis -- [18F]fluorodeoxyglucose-PET; Nuclear medicine -- Periodicals; 616.07575
• DOI: 10.1097/MNM.0000000000001531
• Languages: English
• ISSNs: 0143-3636

Abstract

Abstract : Supplemental Digital Content is available in the text. Abstract : Background: Crossed cerebellar diaschisis (CCD) is characterized by hypometabolism and hypoperfusion on molecular imaging in the cerebellum due to a supratentorial lesion on the contralateral side. CCD is a well-established phenomenon in acute or subacute conditions such as infarction but it has been less well described in chronic conditions such as neurodegenerative dementias. Here, we investigate CCD in a large sample of 830 people meeting research criteria for Alzheimer's disease (AD) using [ 18 F]fluorodeoxyglucose-positron emission tomography (FDG-PET). Materials and methods: This study is based on FDG-PET data collected at baseline as part of two large-scale Phase III clinical trials of a novel tau aggregation inhibitor medication, methylthioninium in mild to moderate AD participants. Quantification of FDG-PET hypometabolism was carried out using standardized uptake value ratio (SUVR), with the pons as the comparison region. SUVR was compared in different regions of interest between the right and left hemispheres of the brain and cerebellum in people with mild AD (Mini-Mental State Examination score ≥ 20). Results: Comparison of SUVR in different brain regions demonstrated significant differences in the temporal, occipital and cerebellar cortices. Right and left asymmetry was noted with lower SUVR in the left temporal and occipital regions, whereas SUVR was lower in the right side of the cerebellum. Conclusion: Here, we found robust evidence of CCD in a large sample of people with AD, a chronic neurodegenerative condition. The presence of this phenomenon in AD opens up a new avenue of research in AD pathogenesis and has the potential to change future diagnostic and therapeutic strategies.